rash on her belly; rash on her breasts; rash on top of her back; rash on right foot; Flu like symptoms; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu like symptoms), RASH (rash on her belly), RASH (rash on her breasts), RASH (rash on top of her back) and RASH (rash on right foot) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination.     The patient's past medical history included Hypertension since an unknown date, Asthma since an unknown date and Diabetes since an unknown date. Concurrent medical conditions included Drug allergy (Sulfa) and Penicillin allergy. Concomitant products included MONTELUKAST, VERAPAMIL, LOSARTAN and FLUTICASONE PROPIONATE (PROAIR [FLUTICASONE PROPIONATE]) for an unknown indication.    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Feb-2021, the patient experienced INFLUENZA LIKE ILLNESS (Flu like symptoms). On 11-Feb-2021, the patient experienced RASH (rash on her belly), RASH (rash on her breasts), RASH (rash on top of her back) and RASH (rash on right foot). At the time of the report, INFLUENZA LIKE ILLNESS (Flu like symptoms) had resolved and RASH (rash on her belly), RASH (rash on her breasts), RASH (rash on top of her back) and RASH (rash on right foot) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided.  No treatment details were reported. This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 18-Feb-2021 and was forwarded to Moderna on 19-Feb-2021.    This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu like symptoms), RASH (rash on her belly), RASH (rash on her breasts), RASH (rash on top of her back) and RASH (rash on right foot) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination.     The patient's past medical history included Hypertension since an unknown date, Asthma since an unknown date and Diabetes since an unknown date. Concurrent medical conditions included Drug allergy (Sulfa) and Penicillin allergy. Concomitant products included MONTELUKAST, VERAPAMIL, LOSARTAN and FLUTICASONE PROPIONATE (PROAIR [FLUTICASONE PROPIONATE]) for an unknown indication.    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Feb-2021, the patient experienced INFLUENZA LIKE ILLNESS (Flu like symptoms). On 11-Feb-2021, the patient experienced RASH (rash on her belly), RASH (rash on her breasts), RASH (rash on top of her back) and RASH (rash on right foot). At the time of the report, INFLUENZA LIKE ILLNESS (Flu like symptoms) had resolved and RASH (rash on her belly), RASH (rash on her breasts), RASH (rash on top of her back) and RASH (rash on right foot) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided.  No treatment details were reported.